Adobe Acrobat Viewer is required to view Adobe Acrobat (PDF) files. If you don't have Acrobat Viewer already installed, click here to download it now.
Over 3,000,000 downloads of this material so far!
Page 2 is the COWS (Clinical Opiate Withdrawal Scale) to help in gauging withdrawal symptoms.
The most downloaded item on naabt.org: TIP 40: Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. This best-practice guideline for the treatment of substance use disorders provides consensus- and evidence-based guidance on the use of buprenorphine for the treatment of opioid addiction.
All TIPs are available directly from the US Health Department in PDF and hardcopy form.
(TIP 39) Substance Abuse Treatment and Family Therapy
(TIP 41) Substance Abuse Treatment: Group Therapy
(TIP 42) Substance Abuse Treatment for Persons With Co-Occurring Disorders
(TIP 43) Medication-Assisted Treatment for Opioid Addiction in Treatment Programs
(TIP 44) Substance Abuse Treatment for Adults in the Criminal Justice System
(TIP 45) Detoxification and Substance Abuse Treatment
Order your own hard copies of TIPs for free from the US Health Department
(Hi-Res JPEG image suitable for photo printers, 2MB)
PowerPoint slides of this can be downloaded as well.
The "Bowling Ball" analogy, written by Dr. Richard Gracer.
This important addition to a patient's wallet includes spaces for not only important contact numbers for the patient, but also important resources for healthcare workers unfamiliar with buprenorphine.
Directs healthcare workers in an emergency to:
Pharmacies can order these refills for their counter displays here
The NAABT Patient/Physician Matching System (PPMS) confidentially connects patients with participating certified buprenorphine-prescribing physicians. This instruction sheet shows how to register and use the system to contact patients seeking buprenorphine treatment.
By choosing language that is not stigmatizing, we can begin to dismantle the negative stereotype associated with opioid addiction. Explanations of why certain words and phrases are stigmatizing and suggestions for alternate, non-stigmatizing replacements are suggested as a start in reducing the stigma associated with addiction.
Released February 13, 2007, this NIDA (National Institute on Drug Abuse) 30-page full-color booklet explains in layman's terms how science has revolutionized the understanding of drug addiction as a brain disease that affects behavior. NIDA hopes this new publication will help reduce stigma against addictive disorders.
This NIDA Notes Series "A Collection of articles that address Research on Heroin (NN0023) contains 17 studies and articles about heroin addiction, and the treatment of, including buprenorphine treatment.
"Practical Considerations for the Clinical Use of Buprenorphine" August, 2004. Written by practicing certified buprenorphine physicians, the guide provides a real world assessment of the methods and issues with using buprenorphine in an office based environment.
This 1992 "Buprenorphine: An Alternative Treatment for Opioid Dependence" monograph is based on the papers and discussions from a technical review on "Buprenorphine: An Alternative Treatment for Opioid Dependence" held on March 16-17, 1989, in Rockville, MD. sponsored by (NIDA).
Buprenorphine Study: Effects of Buprenorphine Maintenance Dose on mu-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers – Mark K Greenwald, Chris-Ellyn Johanson, David E Moody, James H Woods, Michael R Kilbourn, Robert A Koeppe, Charles R Schuster and Jon-Kar Zubieta (2003)
"The Neurobiology of Opioid Dependence: Implications for Treatment" 2002 "Opioid tolerance, physical dependence and addiction are all manifestations of brain changes resulting from chronic opioid use and misuse. The patient's struggle for recovery is in great part a struggle to overcome the effects of these changes..."
Pain and addiction co-occur frequently, and each can make the other more difficult to treat. This article discusses the neurobiology and clinical presentation of pain and its synergies with substance use disorders, presents methodical approaches to the evaluation and treatment of pain that co-occurs with substance use disorders, and provides practical guidelines for the use of opioids to treat pain in individuals with histories of addiction.
This short booklet provides basic information about the use of buprenorphine in medication-assisted treatment for opioid addiction. It describes how buprenorphine works, the proper use of the medication, and common side effects. It also explains how buprenorphine fits into the overall recovery process. The booklet is for patients entering medication-assisted treatment for opioid addiction, and it may be useful to patients' family members and friends. SAMHSA, 2009
Substance Use Disorders: A guide to the Use of Language. Rev. 4/12/04 This guide was prepared by TASC, Inc. under contract for the Center for Substance Abuse Treatment (CSAT), Substance Abuse and Mental Health Services Administration (SAMHSA), part of the U.S. Department of Health and Human Services (DHHS), 2004.